Inventor · disambiguated record
Peiying Liu
Also filed as: LIU PEIYING
18 granted patents·2 pending applications·146 citations·filing 1999–2019
93Inventor score
Files withBRISTOL MYERS SQUIBB CO11RIGEL PHARMACEUTICALS INC3VELAPARTHI UPENDER2BAYER AG1BAYER PHARMACEUTICALS CORP1
Top patents by PatentIndex Score
20 records- 0194US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 0293US7223757B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·16 cites·21 claims
- 0389US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 0486US6784167B217-beta-hydroxysteroid dehydrogenase-II inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Aug 31, 2004·35 cites·17 claims
- 0583US6353006B1Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agentsBAYER AG·Filed 1999·Granted Mar 5, 2002·33 cites·7 claims
- 0682US9556179B2Substituted imidazoles as casein kinase 1 D/E inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 31, 2017·9 cites·15 claims
- 0778US9884868B2TGF-beta inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Feb 6, 2018·2 cites·36 claims
- 0874US9145419B2Imidazopyridazinyl compoundsVELAPARTHI UPENDER·Filed 2011·Granted Sep 29, 2015·3 cites·8 claims
- 0974US7081454B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 25, 2006·6 cites·20 claims
- 1066US9475817B2Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Oct 25, 2016·1 cites·12 claims
- 1166US9273058B2Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 1, 2016·1 cites·14 claims
- 1258US11352360B2TGF-beta inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 7, 2022·0 cites·21 claims
- 1356US9242967B2Substituted bicyclic heteroaryl compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 26, 2016·0 cites·11 claims
- 1456US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 1555US10287295B2TGF-β inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·0 cites·20 claims
- 1653US9598423B2Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 21, 2017·0 cites·13 claims
- 1749US8415340B2Triazine kinase inhibitorsVELAPARTHI UPENDER·Filed 2008·Granted Apr 9, 2013·0 cites·14 claims
- 1843US10961239B2TGF beta receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 30, 2021·0 cites·11 claims
- 1942US2016122358A1Novel substituted pyrazolo-piperazines as casein kinase 1 d/e inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2041US2003207865A1Substituted 2-arylimino heterocycles and compositions containing them for use as progesterone receptor binding agentsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peiying Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →